Status:
TERMINATED
Study of the Effect of FLUTTER® VRP1 (PEP and Oscillating High Frequency).
Lead Sponsor:
University of Sao Paulo
Conditions:
Bronchiectasis
Eligibility:
All Genders
20-85 years
Phase:
PHASE1
Brief Summary
The research sought to assess the effects of Flutter ® VRP1 in patients with bronchiectasis.
Detailed Description
Bronchiectasis is an airway disease with many etiologies characterized pathologically by the abnormal permanent dilatation of bronchi, caused mainly by the perpetuation of inflammatory processes induc...
Eligibility Criteria
Inclusion
- Non Cystic Fibrosis Bronchiectasis
- Amount of secretion sufficient for analysis
- Capable of fulfilling the experimental protocol
Exclusion
- Acute pulmonary disease
- Presence of any respiratory infection in the last four weeks
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01209546
Start Date
July 1 2007
End Date
December 1 2010
Last Update
June 28 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine of Ribeirão Preto, University of Sao Paulo
Ribeirão Preto, São Paulo, Brazil, 14049-900